Most were diagnosed with CVD within the last 5 years and a high proportion of participants were on relevant optimal CHF therapies, including diuretics (92%), beta blockers (62%) and Angiotensin Converting enzymes (55%) as shown in Table 2. The gene discussed is ACE; the disease is congestive heart failure.